In the BioHarmony Drug Report Database

"Preview" Icon

Deferasirox

Exjade, Jadenu, Jadenu Sprinkle (deferasirox) is a small molecule pharmaceutical. Deferasirox was first approved as Exjade on 2005-11-02. It is used to treat iron overload in the USA. It has been approved in Europe to treat beta-thalassemia and iron overload. Exjade’s patent is valid until 2034-11-21 (FDA).

 

Trade Name

 

Exjade
 

Common Name

 

deferasirox
 

ChEMBL ID

 

CHEMBL550348
 

Indication

 

beta-thalassemia, iron overload
 

Drug Class

 

Image (chem structure or protein)

Deferasirox structure rendering